The Pearl Psychedelic Institute, identified by EIN 85-4272437, is dedicated to advancing the study and understanding of psychedelic medicines through research, treatment, training, and community education, particularly in the areas of brain disorders and health. With an operating budget of $537.6K and total revenue of $382.7K for the 2024 filing year, the organization has received significant funding from various sources, none of which contribute 50% or more of its revenue. For more information, visit their website at www.pearlpsychedelicinstitute.org.